Beyond the Breaking News

Novartis receives Health Canada approval for VANRAFIA™ (atrasentan tablet) for proteinuria reduction in adults with primary immunoglobulin A nephropathy (IgAN)

United States News News

Novartis receives Health Canada approval for VANRAFIA™ (atrasentan tablet) for proteinuria reduction in adults with primary immunoglobulin A nephropathy (IgAN)
United States Latest News, United States Headlines

VANRAFIATM (atrasentan tablets) is indicated to reduce proteinuria in adults with IgAN at risk of rapid disease progression, generally a urine

is indicated to reduce proteinuria in adults with IgAN at risk of rapid disease progression, generally a urine protein-to-creatinine ratio ≥1.5 g/g.

¹demonstrated a statistically significant reduction in 24-hour UPCR at Week 36 compared with placebo. ¹/CNW/ — Novartis Pharmaceuticals Canada Inc. announced today that Health Canada has granted approval for VANRAFIA for proteinuria reduction in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression, generally a urine protein-to-creatinine ratio ≥ 1.5 g/g.

¹ IgAN is an autoimmune kidney disease that occurs when clumps of immunoglobulin A and antibodies are deposited in the kidneys, causing inflammation and kidney damage which leads to blood and protein leaking into the urine. The Health Canada authorization is based on a prespecified interim analysis results at 36 weeks of the Phase III ALIGN study, a randomized, double-blind, placebo-controlled study in adults ≥ 18 years with biopsy-proven primary IgAN, estimated glomerular filtration rate ≥ 30 mL/min/1.73 m² and total urine protein ≥ 1 g/day who were on a stable dose of maximally tolerated renin-angiotensin system inhibitor therapy.

¹ is a potent and highly selective Endothelin A receptor antagonist, for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy . ¹ VANRAFIAAbout Novartis Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.

In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 500 people to serve the evolving needs of patients and the healthcare system and invests over $36 million in R&D yearly in the country. Reimagine medicine with us: Visit us at

GooglePlease follow us on Google to support us
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TheStarPhoenix /  🏆 253. in US

 

United States Latest News, United States Headlines

Similar News: You can also read news stories similar to this one that we have collected from other news sources.

Dem governor escalates McConnell health demands, cites response to past Trump health concernsDem governor escalates McConnell health demands, cites response to past Trump health concernsKentucky Gov. Andy Beshear demands Sen. Mitch McConnell reveal his undisclosed medical condition as the 84-year-old remains absent from the Senate.
Read more »

Talking Health: Why focusing on mental health matters during cancer fightTalking Health: Why focusing on mental health matters during cancer fightDr. Emily Tanzler, a radiation oncologist with Cancer Specialists of North Florida, joined us on The Morning Show to discuss ways to maintain control of your life after a cancer diagnosis.
Read more »

Canada and Quebec build on partnership to strengthen youth mental healthMONTREAL, July 13, 2026 /CNW/ - Young people across Canada are struggling with their mental health. Timely access to the right services and supports
Read more »

Team Canada Wins 2026 Canada Cup Championship, TC Colorado Leads All-Star TeamTeam Canada Wins 2026 Canada Cup Championship, TC Colorado Leads All-Star TeamTeam Canada captured the 2026 Canada Cup Championship, while TC Colorado earned top honors with multiple selections to the tournament All-Star Team.
Read more »



Render Time: 2026-08-12 23:57:11